News & Media > BHIVA comment on Lancet HIV paper highlighting prevalence of recreational drug use and increased risk of condomless sex among HIV-positive men who have sex with men (MSM)

BHIVA comment on Lancet HIV paper highlighting prevalence of recreational drug use and increased risk of condomless sex among HIV-positive men who have sex with men (MSM)

Monday 8 September 2014

Commenting on new research1 published in The Lancet HIV, BHIVA Chair Dr David Asboe, said: "The prevalence of multiple drug use and condomless sex among MSM, both with or without HIV is of great concern to HIV clinicians, due to the increased risk of HIV transmission, and also transmission of other STIs including Hepatitis C. Recreational drug use is also implicated in debilitating psychological problems, including depression.

"While this research offers some reassurance that only a small minority of MSM who use multiple types of recreational drug are having condomless sex, it provides a timely reminder that all of us working in the HIV field must continue to raise awareness of the issues. Events such as National HIV Testing Week (22-30 Nov) provide us with a useful platform to do so."
 

1 http://press.thelancet.com/MSM.pdf




For further information or comment, please contact Curium Communications:
Jon Cope: 07867 508212
[email protected]

About BHIVA
Founded in 1995, BHIVA is a well-established organisation which is committed to providing excellence in the care of those living with and affected by HIV. It acts as a national advisory body to professions and other organisations on all aspects of HIV care. BHIVA also provides a national platform for HIV care and contributes representatives for international, national and local committees dealing with HIV care. In addition, BHIVA works to promote undergraduate, postgraduate and continuing medical education within HIV care. Visit www.bhiva.org for more information about BHIVA, and follow us on Twitter @BritishHIVAssoc